Advanced search
Publication Cover
Journal of Market Access & Health Policy Volume 11, 2023 - Issue 1
Journal homepage
726
Views
0
CrossRef citations to date
0
Altmetric
Original Research Article

Health-related quality of life in health states corresponding to different stages of perianal fistula associated with Crohn’s disease: a quantitative evaluation of patients and non-patients in Japan

Masafumi Katoa Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, JapanCorrespondence[email protected]
View further author information
,
Mariko Yoneyama-Hirozanea Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, JapanView further author information
,
Katsuhiko Iwasakib Department of Data Science, Medilead, Inc, Tokyo, JapanView further author information
,
Mao Matsubayashic Department of Gastroenterology, Graduate School of Medicine, Yokohama City University, Yokohama, JapanView further author information
&
Ataru Igarashid Unit of Public Health and Preventive Medicine, School of Medicine, Yokohama City University, Yokohama, Japan;e Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, JapanView further author information
Article: 2166374 | Received 19 Jun 2022, Accepted 03 Jan 2023, Published online: 15 Jan 2023

References

  • Bell SJ, Williams AB, Wiesel P, et al. The clinical course of fistulating Crohn’s disease. Aliment Pharmacol Ther. 2003;17(9):1145–11.
  • Sciaudone G, Di Stazio C, Limongelli P, et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg. 2010;53(5):299–304.
  • Marzo M, Felice C, Pugliese D, et al. Management of perianal fistulas in Crohn’s disease: an up-to-date review. World J Gastroenterol. 2015;21(5):1394–1403. DOI:10.3748/wjg.v21.i5.1394
  • de Zoeten EF, Pasternak BA, Mattei P, et al. Diagnosis and treatment of perianal Crohn disease: nASPGHAN clinical report and consensus statement. J Pediatr Gastroenterol Nutr. 2013;57(3):401–412.
  • Falconi M, Pederzoli P. The relevance of gastrointestinal fistulae in clinical practice: a review. Gut. 2001;49(Suppl 4):iv2–10.
  • Maconi G, Gridavilla D, Vigano C, et al. Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission. Int J Colorectal Dis. 2014;29(10):1285–1290. DOI:10.1007/s00384-014-1935-6
  • Mahadev S, Young JM, Selby W, et al. Quality of life in perianal Crohn’s disease: what do patients consider important? Dis Colon Rectum. 2011;54(5):579–585.
  • Grouin A, Brochard C, Siproudhis L, et al. Perianal Crohn’s disease results in fewer pregnancies but is not exacerbated by vaginal delivery. Dig Liver Dis. 2015;47(12):1021–1026. DOI:10.1016/j.dld.2015.08.001
  • Vollebregt PF, van Bodegraven AA, Markus-DeKwaadsteniet TML, et al. Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2018;47(9):1253–1260.
  • Tosh JC, Longworth LJ, George E. Utility values in National Institute for Health and Clinical Excellence (NICE) technology appraisals. Value Health. 2011;14(1):102–109.
  • Longworth L, Rowen D. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health. 2013;16(1):202–210.
  • Rabin R, de Charro F. EQ-SD: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–343.
  • Horsman J, Furlong W, Feeny D, et al. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1(1):54.
  • Arseneau KO, Cohn SM, Cominelli F, et al. Cost-utility of initial medical management for Crohn’s disease perianal fistulae. Gastroenterol. 2001;120(7):1640–1656.
  • Longworth L, Fountain D, Singh J, et al. Elicitation of health-related utility in perianal fistula in Crohn’s disease. Patient. 2019 Jun;12(3):339–348. 10.1007/s40271-018-0352-2.
  • TLV. Tandvårds- och läkemedelsförmånsverkets allmänna råd. 2017. Accessed 11 Nov 2021. https://www.tlv.se/download/18.467926b615d084471ac3230c/1510316374332/TLVAR_2017_1.pdf.
  • NICE. Guide to the methods of technology appraisal. 2013. Accessed 11 Nov 2021. https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781.
  • Medilead, Inc. Research panel MHP (Medilead Healthcare Panel). Accessed 11 Nov 2022. https://www.medi-l.com/.
  • Yamaguchi H, Iwasaki K, Shoji A, et al. Health‒related Quality of Life (QoL) in Japanese patients with cancer: a large‒scale questionnaire survey using EQ‒5D‒5L. Ther Res. 2020;41(12):949–955.
  • Masaki H, Ishizaki S, Uenishi T, et al. A survey of theimpact of COVID‒19 on the visiting frequency of Japanese Patients with gastrointestinal diseases. Jpn Pharmacol Ther. 2021;49(1):17–39.
  • Statistics Bureau, Ministry of Internal Affairs and Communications. Population Estimates as of October 1, 2019. Population by Age (Single Years), Sex and Sex ratio – Total population, Japanese population, Table 1: Population by Age (Single Years) and Sex. https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&toukei=00200524&tstat=000000090001&cycle=7&year=20190&month=0&tclass1=000001011679. Accessed 13 Sept 2021.
  • Ikeda S, Shiroiwa T, Igarashi A, et al. Developing a Japanese version of the EQ-5D-5L value set. J Natl Inst Public Health. 2015;64:47–55.
  • Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford, United Kingdom: Oxford University Press; 2015.
  • Smith DM, Sherriff RL, Damschroder L, et al. Misremembering colostomies? former patients give lower utility ratings than do current patients. Health Psychol. 2006;25(6):688–695.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.